Literature DB >> 3309167

Effects of moenomycin on Escherichia coli.

Y van Heijenoort1, M Leduc, H Singer, J van Heijenoort.   

Abstract

The antibiotic moenomycin is a valuable biochemical tool for studying the metabolism of peptidoglycan and the autolytic system in Escherichia coli, since as a specific inhibitor of peptidoglycan polymerases it can efficiently promote cell lysis. In liquid media the bacteriolytic effect on E. coli K12 was dependent on the concentration of moenomycin, on growth phase and on growth rate. Before lysis cells underwent major morphological alterations. In sucrose-containing medium complete transformation to osmotically sensitive spheroplasts was easily achieved by addition of moenomycin. The minimum inhibitory concentration of the antibiotic varied with the strain of E. coli and was highly dependent on the growth medium. A tritiated derivative of moenomycin, [3H]decahydromoenomycin A, was prepared and found to have the same inhibiting efficiency. Its binding to E. coli membranes and membrane proteins was investigated. The absence of irreversible binding suggested that moenomycin might be a competitive inhibitor of the peptidoglycan polymerases. Spontaneous moenomycin resistant variants were isolated at a frequency of about 10(-9).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3309167     DOI: 10.1099/00221287-133-3-667

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  21 in total

Review 1.  Sortases and the art of anchoring proteins to the envelopes of gram-positive bacteria.

Authors:  Luciano A Marraffini; Andrea C Dedent; Olaf Schneewind
Journal:  Microbiol Mol Biol Rev       Date:  2006-03       Impact factor: 11.056

2.  Effects of flavophospholipol on resistance in fecal Escherichia coli and enterococci of fattening pigs.

Authors:  A E van den Bogaard; M Hazen; M Hoyer; P Oostenbach; E E Stobberingh
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

3.  Membrane intermediates in the peptidoglycan metabolism of Escherichia coli: possible roles of PBP 1b and PBP 3.

Authors:  Y van Heijenoort; M Gómez; M Derrien; J Ayala; J van Heijenoort
Journal:  J Bacteriol       Date:  1992-06       Impact factor: 3.490

Review 4.  Morphological and ultrastructural changes in bacterial cells as an indicator of antibacterial mechanism of action.

Authors:  T P Tim Cushnie; Noëlle H O'Driscoll; Andrew J Lamb
Journal:  Cell Mol Life Sci       Date:  2016-07-08       Impact factor: 9.261

Review 5.  Moenomycin family antibiotics: chemical synthesis, biosynthesis, and biological activity.

Authors:  Bohdan Ostash; Suzanne Walker
Journal:  Nat Prod Rep       Date:  2010-08-23       Impact factor: 13.423

Review 6.  Peptidoglycan hydrolases of Escherichia coli.

Authors:  Jean van Heijenoort
Journal:  Microbiol Mol Biol Rev       Date:  2011-12       Impact factor: 11.056

7.  Resistance and tolerance to tropodithietic acid, an antimicrobial in aquaculture, is hard to select.

Authors:  Cisse Hedegaard Porsby; Mark A Webber; Kristian Fog Nielsen; Laura J V Piddock; Lone Gram
Journal:  Antimicrob Agents Chemother       Date:  2011-01-24       Impact factor: 5.191

8.  Identification, purification, and characterization of transpeptidase and glycosyltransferase domains of Streptococcus pneumoniae penicillin-binding protein 1a.

Authors:  A M Di Guilmi; N Mouz; J P Andrieu; J Hoskins; S R Jaskunas; J Gagnon; O Dideberg; T Vernet
Journal:  J Bacteriol       Date:  1998-11       Impact factor: 3.490

9.  The glycosyltransferase domain of penicillin-binding protein 2a from Streptococcus pneumoniae catalyzes the polymerization of murein glycan chains.

Authors:  Anne Marie Di Guilmi; Andréa Dessen; Otto Dideberg; Thierry Vernet
Journal:  J Bacteriol       Date:  2003-08       Impact factor: 3.490

Review 10.  Antimicrobial growth promoters used in animal feed: effects of less well known antibiotics on gram-positive bacteria.

Authors:  Patrick Butaye; Luc A Devriese; Freddy Haesebrouck
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.